Connection

ROBIN PARIHAR to Killer Cells, Natural

This is a "connection" page, showing publications ROBIN PARIHAR has written about Killer Cells, Natural.
Connection Strength

2.708
  1. Memory NK cells to forget relapsed AML. Blood. 2022 03 17; 139(11):1607-1608.
    View in: PubMed
    Score: 0.675
  2. NK Cells Expressing a Chimeric Activating Receptor Eliminate MDSCs and Rescue Impaired CAR-T Cell Activity against Solid Tumors. Cancer Immunol Res. 2019 03; 7(3):363-375.
    View in: PubMed
    Score: 0.542
  3. Src homology 2-containing inositol 5'-phosphatase 1 negatively regulates IFN-gamma production by natural killer cells stimulated with antibody-coated tumor cells and interleukin-12. Cancer Res. 2005 Oct 01; 65(19):9099-107.
    View in: PubMed
    Score: 0.216
  4. NK Cell Therapeutics for Hematologic Malignancies: from Potential to Fruition. Curr Hematol Malig Rep. 2023 12; 18(6):264-272.
    View in: PubMed
    Score: 0.188
  5. IL-12 enhances the natural killer cell cytokine response to Ab-coated tumor cells. J Clin Invest. 2002 Oct; 110(7):983-92.
    View in: PubMed
    Score: 0.175
  6. Detection of response to tumor microenvironment-targeted cellular immunotherapy using nano-radiomics. Sci Adv. 2020 07; 6(28):eaba6156.
    View in: PubMed
    Score: 0.150
  7. Large-Scale Culture and Genetic Modification of Human Natural Killer Cells for Cellular Therapy. Methods Mol Biol. 2016; 1441:195-202.
    View in: PubMed
    Score: 0.110
  8. Gene expression profiling of the human natural killer cell response to Fc receptor activation: unique enhancement in the presence of interleukin-12. BMC Med Genomics. 2015 Oct 15; 8:66.
    View in: PubMed
    Score: 0.108
  9. IL-12 enhances the antitumor actions of trastuzumab via NK cell IFN-? production. J Immunol. 2011 Mar 15; 186(6):3401-9.
    View in: PubMed
    Score: 0.078
  10. Colocalization of the IL-12 receptor and FcgammaRIIIa to natural killer cell lipid rafts leads to activation of ERK and enhanced production of interferon-gamma. Blood. 2008 Apr 15; 111(8):4173-83.
    View in: PubMed
    Score: 0.063
  11. Interleukin-21 enhances NK cell activation in response to antibody-coated targets. J Immunol. 2006 Jul 01; 177(1):120-9.
    View in: PubMed
    Score: 0.057
  12. Natural killer cells produce T cell-recruiting chemokines in response to antibody-coated tumor cells. Cancer Res. 2006 Jan 01; 66(1):517-26.
    View in: PubMed
    Score: 0.055
  13. CpG-containing oligodeoxynucleotides act through TLR9 to enhance the NK cell cytokine response to antibody-coated tumor cells. J Immunol. 2005 Aug 01; 175(3):1619-27.
    View in: PubMed
    Score: 0.053
  14. Differential expression of SHIP1 in CD56bright and CD56dim NK cells provides a molecular basis for distinct functional responses to monokine costimulation. Blood. 2005 Apr 15; 105(8):3011-8.
    View in: PubMed
    Score: 0.051
  15. A phase I study of interleukin 12 with trastuzumab in patients with human epidermal growth factor receptor-2-overexpressing malignancies: analysis of sustained interferon gamma production in a subset of patients. Clin Cancer Res. 2004 Aug 01; 10(15):5027-37.
    View in: PubMed
    Score: 0.050
  16. Natural killer cells contribute to the lethality of a murine model of Escherichia coli infection. Surgery. 2002 Aug; 132(2):205-12.
    View in: PubMed
    Score: 0.043
  17. Administration of two macrophage-derived interferon-gamma-inducing factors (IL-12 and IL-15) induces a lethal systemic inflammatory response in mice that is dependent on natural killer cells but does not require interferon-gamma. Cell Immunol. 2002 Mar-Apr; 216(1-2):31-42.
    View in: PubMed
    Score: 0.042
  18. MICA-Expressing Monocytes Enhance Natural Killer Cell Fc Receptor-Mediated Antitumor Functions. Cancer Immunol Res. 2017 09; 5(9):778-789.
    View in: PubMed
    Score: 0.031
  19. The antitumor effects of IFN-alpha are abrogated in a STAT1-deficient mouse. J Clin Invest. 2003 Jul; 112(2):170-80.
    View in: PubMed
    Score: 0.012
  20. A phase I trial of escalating doses of trastuzumab combined with daily subcutaneous interleukin 2: report of cancer and leukemia group B 9661. Clin Cancer Res. 2002 Dec; 8(12):3718-27.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.